医学研究与教育 ›› 2016, Vol. 33 ›› Issue (5): 30-34.DOI: 10.3969/j.issn.1674-490X.2016.05.007

• 综述 • 上一篇    下一篇

脓毒症致急性呼吸窘迫综合征的研究进展

瞿海龙,周英莲,刘鹏,张新欣,彭广军   

  1. 河北大学附属医院急诊科, 河北 保定 071000
  • 收稿日期:2016-05-04 出版日期:2016-10-25 发布日期:2016-10-25
  • 通讯作者: 彭广军(1965—),男,河北枣强人,主任医师,硕士,主要从事急救医学临床和科研。E-mail: pgj650652@sina.com
  • 作者简介:瞿海龙(1976—),男,河北涞水人,副主任医师,硕士,主要从事急救医学临床和科研。 E-mail: hailongju1976@sina.com

Developments on acute respiratory distress syndrome induced by sepsis

JU Hailong,ZHOU Yinglian,LIU Peng,ZHANG Xinxin,PENG Guangjun   

  1. Emergency Department, Affiliated Hospital of Hebei University, Baoding 071000, China
  • Received:2016-05-04 Online:2016-10-25 Published:2016-10-25

摘要: 严重脓毒症或脓毒症休克是指由病原微生物感染引起的机体过度炎性反应。急性呼吸窘迫综合征是严重脓毒症的一个致命性并发症,此类患者具有较高的病死率。在过去的十几年里,对于急性呼吸窘迫综合征治疗取得了显著进步,包括保护性的肺通气策略、俯卧位通气、神经肌肉阻滞剂的应用、体外膜式氧合,然而病死率仍高居不下。对脓毒症的早期治疗和急性呼吸窘迫综合征早期发现可减少疾病的进展。此外仍需对脓毒症导致的急性呼吸窘迫综合征的发病机制和新型治疗手段进行研究,以便发现更有希望的治疗方法。

关键词: 脓毒症, 休克, 急性呼吸窘迫综合征

Abstract: Severe sepsis or septic shock is characterized by an excessive inflammatory response to infectious pathogens.Acute respiratory distress syndrome(ARDS)is a devastating complication of severe sepsis,in which patients have high mortality.Advances in treatment modalities including lung protective ventilation,prone positioning,use of neuromuscular blockade,and extracorporeal membrane oxygenation,have improved the outcome over recent decades,nevertheless,the mortality rate still remains high.Timely treatment of underlying sepsis and early identification of patients at risk of ARDS can help to decrease its development.In addition,further studies are needed regarding pathogenesis and novel therapies in order to show promising future treatments of sepsis-induced ARDS.

Key words: sepsis, shock, acute respiratory distress syndrome

中图分类号: